2,335 Shares in Tenet Healthcare Corporation $THC Acquired by R Squared Ltd

R Squared Ltd purchased a new position in Tenet Healthcare Corporation (NYSE:THC) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 2,335 shares of the company’s stock, valued at approximately $474,000.

Several other hedge funds and other institutional investors have also recently modified their holdings of the stock. William B. Walkup & Associates Inc. purchased a new position in Tenet Healthcare during the third quarter valued at $32,000. Canada Pension Plan Investment Board purchased a new position in shares of Tenet Healthcare during the 2nd quarter valued at about $35,000. Westside Investment Management Inc. grew its stake in shares of Tenet Healthcare by 100.0% during the 3rd quarter. Westside Investment Management Inc. now owns 192 shares of the company’s stock valued at $39,000 after acquiring an additional 96 shares during the period. Trust Co. of Vermont bought a new stake in Tenet Healthcare during the 3rd quarter worth approximately $41,000. Finally, True Wealth Design LLC boosted its position in shares of Tenet Healthcare by 238.2% in the second quarter. True Wealth Design LLC now owns 257 shares of the company’s stock worth $45,000 after purchasing an additional 181 shares during the period. 95.44% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of research analysts recently weighed in on the stock. Guggenheim lifted their target price on shares of Tenet Healthcare from $257.00 to $271.00 and gave the company a “buy” rating in a research note on Friday, February 13th. Weiss Ratings upgraded Tenet Healthcare from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Monday, December 29th. Wall Street Zen downgraded Tenet Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Saturday, February 21st. UBS Group upped their price target on Tenet Healthcare from $260.00 to $288.00 and gave the stock a “buy” rating in a research note on Thursday, February 12th. Finally, Barclays lifted their price objective on shares of Tenet Healthcare from $240.00 to $257.00 and gave the company an “overweight” rating in a research report on Friday, February 13th. One research analyst has rated the stock with a Strong Buy rating, eighteen have assigned a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $247.67.

Key Headlines Impacting Tenet Healthcare

Here are the key news stories impacting Tenet Healthcare this week:

• Positive Sentiment: Zacks raised its FY2026 EPS estimate to $16.76 (from $15.41), aligning with Tenet’s FY2026 guidance range and implying stronger full‑year profitability. This supports valuation (THC P/E ~15.4) and could lift sentiment.
• Positive Sentiment: Zacks increased Q1 2026 and Q2 2026 EPS estimates to $4.14 and $4.10, respectively (Q1 from $3.73; Q2 from $3.68), signaling better near‑term operating momentum.
• Positive Sentiment: Several 2026 quarterly upgrades — Q3 2026 to $4.08 and Q4 2026 to $4.44 — suggest Zacks sees stronger sequential quarters into year‑end, underpinning FY2026 strength.
• Positive Sentiment: Zacks nudged Q1 and Q2 2027 estimates higher in places (Q1 2027 to $4.31; Q2 2027 to $4.75), indicating expectations for continued operational stability into early 2027.
• Neutral Sentiment: Zacks published FY2028 EPS of $17.80 — a forward projection but one quarter/year further out; useful for modeling but less likely to move stock immediately.
• Negative Sentiment: Zacks cut FY2027 EPS to $16.35 from $17.98, a sizable downward revision that signals softer longer‑term growth expectations and may pressure sentiment beyond the current year.
• Negative Sentiment: Notable quarterly downgrades for 2027: Q3 2027 to $4.01 (from $4.38) and Q4 2027 to $3.28 (from $4.82). The Q4 2027 cut is large and could raise concerns about seasonality or margin pressure in late‑cycle periods.

Insiders Place Their Bets

In other Tenet Healthcare news, Director Nadja West sold 2,178 shares of the company’s stock in a transaction that occurred on Monday, December 15th. The stock was sold at an average price of $197.47, for a total transaction of $430,089.66. Following the sale, the director directly owned 28,480 shares in the company, valued at $5,623,945.60. This represents a 7.10% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this link. 0.81% of the stock is owned by insiders.

Tenet Healthcare Stock Down 0.4%

NYSE THC opened at $238.68 on Friday. The stock has a 50 day moving average price of $206.02 and a 200-day moving average price of $199.74. Tenet Healthcare Corporation has a one year low of $109.82 and a one year high of $240.83. The company has a debt-to-equity ratio of 2.18, a quick ratio of 1.68 and a current ratio of 1.76. The company has a market capitalization of $20.76 billion, a P/E ratio of 15.41, a P/E/G ratio of 1.18 and a beta of 1.44.

Tenet Healthcare (NYSE:THC) last released its quarterly earnings data on Wednesday, February 11th. The company reported $4.70 EPS for the quarter, beating the consensus estimate of $4.08 by $0.62. Tenet Healthcare had a net margin of 6.60% and a return on equity of 26.33%. The business had revenue of $5.53 billion during the quarter, compared to analyst estimates of $5.47 billion. During the same quarter last year, the business earned $3.44 earnings per share. Tenet Healthcare’s quarterly revenue was up 8.9% compared to the same quarter last year. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. As a group, equities analysts predict that Tenet Healthcare Corporation will post 12.24 EPS for the current fiscal year.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.